These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 37511503)

  • 21. LOXL2: A potential therapeutic target in the treatment of hepatocellular carcinoma?
    Liu HX; Liu L
    Dig Liver Dis; 2023 Sep; 55(9):1307. PubMed ID: 37088591
    [No Abstract]   [Full Text] [Related]  

  • 22. LncRNA CARMN Affects Hepatocellular Carcinoma Prognosis by Regulating the miR-192-5p/LOXL2 Axis.
    Wang X; Wu S; Yang Y; Zhao J
    Oxid Med Cell Longev; 2022; 2022():9277360. PubMed ID: 36254230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment.
    Zhang J; Zhang Q; Lou Y; Fu Q; Chen Q; Wei T; Yang J; Tang J; Wang J; Chen Y; Zhang X; Zhang J; Bai X; Liang T
    Hepatology; 2018 May; 67(5):1872-1889. PubMed ID: 29171040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
    Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
    Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
    [No Abstract]   [Full Text] [Related]  

  • 25. LOXL4 is downregulated in hepatocellular carcinoma with a favorable prognosis.
    Tian M; Liu W; Jin L; Jiang X; Yang L; Ding Z; Shen Y; Peng Y; Gao D; Li L; Zhou J; Qiu S; Dai Z; Fan J; Shi Y
    Int J Clin Exp Pathol; 2015; 8(4):3892-900. PubMed ID: 26097573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
    Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q
    Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LOXL2 in epithelial cell plasticity and tumor progression.
    Cano A; Santamaría PG; Moreno-Bueno G
    Future Oncol; 2012 Sep; 8(9):1095-108. PubMed ID: 23030485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
    Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
    Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity.
    Almacellas-Rabaiget O; Monaco P; Huertas-Martinez J; García-Monclús S; Chicón-Bosch M; Maqueda-Marcos S; Fabra-Heredia I; Herrero-Martín D; Rello-Varona S; de Alava E; López-Alemany R; Giangrande PH; Tirado OM
    Cancer Lett; 2020 Apr; 474():1-14. PubMed ID: 31911079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific protein 1(SP1) regulates the epithelial-mesenchymal transition via lysyl oxidase-like 2(LOXL2) in pancreatic ductal adenocarcinoma.
    Kim IK; Lee YS; Kim HS; Dong SM; Park JS; Yoon DS
    Sci Rep; 2019 Apr; 9(1):5933. PubMed ID: 30976063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysfunctional activation of neurotensin/IL-8 pathway in hepatocellular carcinoma is associated with increased inflammatory response in microenvironment, more epithelial mesenchymal transition in cancer and worse prognosis in patients.
    Yu J; Ren X; Chen Y; Liu P; Wei X; Li H; Ying G; Chen K; Winkler H; Hao X
    PLoS One; 2013; 8(2):e56069. PubMed ID: 23418512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells.
    Lin ZY; Chuang YH; Chuang WL
    Biomed Pharmacother; 2012 Oct; 66(7):525-9. PubMed ID: 22739041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.
    Li R; Wang Y; Zhang X; Feng M; Ma J; Li J; Yang X; Fang F; Xia Q; Zhang Z; Shang M; Jiang S
    Mol Cancer; 2019 Jan; 18(1):18. PubMed ID: 30704479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition.
    Cao Z; Sun B; Zhao X; Zhang Y; Gu Q; Liang X; Dong X; Zhao N
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications.
    García-Vilas JA; Medina MÁ
    World J Gastroenterol; 2018 Sep; 24(33):3695-3708. PubMed ID: 30197476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro.
    Moon HJ; Finney J; Xu L; Moore D; Welch DR; Mure M
    J Biol Chem; 2013 Oct; 288(42):30000-30008. PubMed ID: 24014025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Peng H; Zhang Y; Zhou Z; Guo Y; Huang X; Westover KD; Zhang Z; Chen B; Hua Y; Li S; Xu R; Lin N; Peng B; Shen S
    EBioMedicine; 2019 Aug; 46():105-118. PubMed ID: 31324602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
    Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
    BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
    Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C
    J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.